BioSpace News Archive

Reprocessed Medical Devices Market: Reprocessed cardiovascular medical devices segment accounted for the dominant share of market

The vendor landscape of the global reprocessed medical devices market is significantly consolidated with the leading few companies collectively accounting for a lion’s share in the overall market, observes Transparency Market Research in a recent report.

July 13, 2021
·
5 min read
Point-of-care Diagnostics Market: Home Testing Equipment for Glucose Emerges as Leading Trend

The global point of care diagnostics market is growing at a healthy CAGR. It is expected to receive a boost during the forecast period, taking the market evaluation US$11.7 bn by 2024 end.

July 13, 2021
·
4 min read
Medical Oxygen Concentrators Market: Portable medical oxygen concentrators are expected to dominate the global market

Respiratory diseases are on a rise and this is leading to growth in demand for medical oxygen concentrations market.

July 13, 2021
·
4 min read
Genomics Personalized Health Market: Advancement in Molecular Biology to Boost Market Demand

The global genomics personalized health market is anticpated to be highly fragmented due to presence of large number of palyers in the regional and global market.

July 13, 2021
·
5 min read
Cell Expansion Market: Increasing focus on customized and personalized medicine to drive the market

Transparency Market Research anticipates that the cell expansion market features fragmented vendor landscape owing to a large number of key players operating in the market.

July 13, 2021
·
3 min read
Business

Lung Therapeutics Announces Appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development

Lung Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel therapeutics for orphan, pulmonary diseases and conditions, announced the appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development.

July 13, 2021
·
3 min read
ASLAN Pharmaceuticals Announces Loan Facility Providing Up to $45 Million From K2 HealthVentures Funds extend expected cash runway through late 2023 and enable advancement of clinical program for ASLAN003

ASLAN Pharmaceuticals, a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, announced that it has closed a secured loan facility provided by K2 HealthVentures.

July 13, 2021
·
5 min read
Business

Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results

Bio-Techne Corporation announced that management will host a conference call and webcast on Thursday, August 5, 2021, at 8:00 a.m. CDT to review fourth quarter 2021 financial results.

July 13, 2021
·
2 min read
Business

Gennao Bio Appoints Chris Duke as Chief Operating Officer and Julie Hambleton, M.D., to Board of Directors

Gennao Bio today announced the appointments of Chris Duke as chief operating officer and Julie Hambleton, M.D., as director to the company’s board.

July 13, 2021
·
3 min read
Business

Inozyme Pharma Announces Appointment of Gayle Gironda as Senior Vice President, Human Resources

Inozyme Pharma, Inc. today announced that Gayle Gironda has been appointed as senior vice president of human resources.

July 13, 2021
·
5 min read